These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The molecular basis of IL-10 function: from receptor structure to the onset of signaling. Walter MR Curr Top Microbiol Immunol; 2014; 380():191-212. PubMed ID: 25004819 [TBL] [Abstract][Full Text] [Related]
28. Light-base technology to neutralize viral infections. Bagnato VS; Pinheiro A; Baptista MS J Photochem Photobiol; 2022 Sep; 11():100119. PubMed ID: 35378973 [No Abstract] [Full Text] [Related]
29. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Wilson EB; Yamada DH; Elsaesser H; Herskovitz J; Deng J; Cheng G; Aronow BJ; Karp CL; Brooks DG Science; 2013 Apr; 340(6129):202-7. PubMed ID: 23580528 [TBL] [Abstract][Full Text] [Related]
30. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Wherry EJ; Ha SJ; Kaech SM; Haining WN; Sarkar S; Kalia V; Subramaniam S; Blattman JN; Barber DL; Ahmed R Immunity; 2007 Oct; 27(4):670-84. PubMed ID: 17950003 [TBL] [Abstract][Full Text] [Related]
31. IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection. Brooks DG; Walsh KB; Elsaesser H; Oldstone MB Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3018-23. PubMed ID: 20133700 [TBL] [Abstract][Full Text] [Related]
32. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Teijaro JR; Ng C; Lee AM; Sullivan BM; Sheehan KC; Welch M; Schreiber RD; de la Torre JC; Oldstone MB Science; 2013 Apr; 340(6129):207-11. PubMed ID: 23580529 [TBL] [Abstract][Full Text] [Related]
33. The role of IL-10 in regulating immunity to persistent viral infections. Wilson EB; Brooks DG Curr Top Microbiol Immunol; 2011; 350():39-65. PubMed ID: 20703965 [TBL] [Abstract][Full Text] [Related]
34. Molecular and cellular insights into T cell exhaustion. Wherry EJ; Kurachi M Nat Rev Immunol; 2015 Aug; 15(8):486-99. PubMed ID: 26205583 [TBL] [Abstract][Full Text] [Related]
35. IL-21 is required to control chronic viral infection. Elsaesser H; Sauer K; Brooks DG Science; 2009 Jun; 324(5934):1569-72. PubMed ID: 19423777 [TBL] [Abstract][Full Text] [Related]
36. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Brooks DG; Ha SJ; Elsaesser H; Sharpe AH; Freeman GJ; Oldstone MB Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20428-33. PubMed ID: 19075244 [TBL] [Abstract][Full Text] [Related]
37. IL-10: the master regulator of immunity to infection. Couper KN; Blount DG; Riley EM J Immunol; 2008 May; 180(9):5771-7. PubMed ID: 18424693 [TBL] [Abstract][Full Text] [Related]
38. T cell exhaustion. Wherry EJ Nat Immunol; 2011 Jun; 12(6):492-9. PubMed ID: 21739672 [TBL] [Abstract][Full Text] [Related]